Investigators using their skills to address SARS-CoV-2 and COVID-19 include:
- Roberto Cattaneo, Ph.D.
- Thomas Caulfield, Ph.D. — Drug Discovery, Design and Optimization for Novel Therapeutics Laboratory
- Stephen C. Ekker, Ph.D. — Zebrafish Facility
- Karl J. Clark, Ph.D.
- Haojie Huang, Ph.D. — Cancer Epigenetics and Functional Genomics Lab
- Louis (Jim) J. Maher III, Ph.D. — Nucleic Acid Structure and Recognition Lab
- Georges Mer, Ph.D. — Structural Biology Facility
- Akhilesh Pandey, M.D., Ph.D.
- Jeffery L. Salisbury, Ph.D.
- Matthew J. Schellenberg, Ph.D.
- Liguo Wang, Ph.D.